These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26267211)

  • 41. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
    Chen K; Maley J; Yu PH
    J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solvent exposure of Tyr10 as a probe of structural differences between monomeric and aggregated forms of the amyloid-β peptide.
    Aran Terol P; Kumita JR; Hook SC; Dobson CM; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Dec; 468(4):696-701. PubMed ID: 26551456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies of the growth, evolution, and self-aggregation of β-amyloid fibrils using tapping-mode atomic force microscopy.
    Serem WK; Bett CK; Ngunjiri JN; Garno JC
    Microsc Res Tech; 2011 Jul; 74(7):699-708. PubMed ID: 21698718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study.
    Lemkul JA; Bevan DR
    Biochemistry; 2013 Jul; 52(29):4971-80. PubMed ID: 23855340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
    Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
    Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of peptide products from enzymatic degradation of amyloid beta.
    Rogeberg M; Furlund CB; Moe MK; Fladby T
    Biochimie; 2014 Oct; 105():216-20. PubMed ID: 25010651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific binding of DNA to aggregated forms of Alzheimer's disease amyloid peptides.
    Camero S; Ayuso JM; Barrantes A; Benítez MJ; Jiménez JS
    Int J Biol Macromol; 2013 Apr; 55():201-6. PubMed ID: 23352599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of early stage intermediates in the nucleation phase of Aβ aggregation.
    Zhai J; Lee TH; Small DH; Aguilar MI
    Biochemistry; 2012 Feb; 51(6):1070-8. PubMed ID: 22283417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity.
    Catto M; Arnesano F; Palazzo G; De Stradis A; Calò V; Losacco M; Purgatorio R; Campagna F
    Arch Biochem Biophys; 2014 Oct; 560():73-82. PubMed ID: 25051344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
    Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
    FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
    Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
    Veloso AJ; Kerman K
    Bioelectrochemistry; 2012 Apr; 84():49-52. PubMed ID: 21967982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cu(II) affinity for the Alzheimer's peptide: tyrosine fluorescence studies revisited.
    Alies B; Renaglia E; Rózga M; Bal W; Faller P; Hureau C
    Anal Chem; 2013 Feb; 85(3):1501-8. PubMed ID: 23249207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The molecular structure of Alzheimer β-amyloid fibrils formed in the presence of phospholipid vesicles.
    Niu Z; Zhao W; Zhang Z; Xiao F; Tang X; Yang J
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9294-7. PubMed ID: 24810551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pt(II) compounds interplay with Cu(II) and Zn(II) coordination to the amyloid-β peptide has metal specific consequences on deleterious processes associated to Alzheimer's disease.
    Collin F; Sasaki I; Eury H; Faller P; Hureau C
    Chem Commun (Camb); 2013 Mar; 49(21):2130-2. PubMed ID: 23386213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils.
    Luo J; Wärmländer SK; Gräslund A; Abrahams JP
    Biochemistry; 2014 Oct; 53(40):6302-8. PubMed ID: 25198136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.